Glycomics Market Worth $2.0 Billion by 2025 - Exclusive Report by MarketsandMarkets™
Global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8% according to a new report by MarketsandMarkets™. The growth of this market is mainly driven by increasing R&D spending and funding for proteomics and glycomics research, growth of the proteomics market, and technological advancements in glycomics devices.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
Browse in-depth TOC on "Glycobiology Market"
194 – Tables
29 – Figures
173 – Pages
The enzymes segment accounted for the largest share of the glycomics market, by product
The glycomics market, by enzymes, has been categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzymes segment is expected to dominate the market in 2020 and is projected to grow at the highest CAGR during the forecast period.
Glycomics market for drug discovery & development application is expected to grow at a high rate
By application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the glycomics market, majorly due to the increasing R&D investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
North America is the largest regional market for glycomics products
North America is expected to dominate the global glycomics market, followed by Europe. The largest share of North America is mainly attributed to increasing funding on glycomics research, rising R&D expenditure for drug discovery & development, and the presence of all key players.
The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK).
Get 10% Free Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132685525
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian